Anika Therapeutics, Inc. (ANIK) revenue

Revenue · fiscal 2025
$112.82M

Anika Therapeutics, Inc. (ANIK) reported revenue of $112.82M in fiscal 2025 (the year ended December 31, 2025). That is 5.9% lower than the $119.91M of fiscal 2024. Figures as of 18 Nov 2026, 12:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$112.82M
Change on fiscal 2024
−5.9%
Growth, 5 years
−2.9% a year
Growth, 10 years
+2.0% a year
Highest on record
$147.79Mfiscal 2021
Lowest on record
$40.14Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Anika Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 2.9% a year; over ten years the rate was 2.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was $147.79M in fiscal 2021 and the lowest $40.14M in fiscal 2009.

History · 17 fiscal years

Revenue by fiscal year

Anika Therapeutics, Inc. revenue, year by year

Anika Therapeutics, Inc. (ANIK) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$112.82M 5.9% down
2024$119.91M 0.7% down
2023$120.79M 6.1% up
2022$113.83M 23.0% down
2021$147.79M 13.3% up
2020$130.46M 13.8% up
2019$114.61M 8.6% up
2018$105.56M 6.9% down
2017$113.42M 9.7% up
2016$103.38M 11.2% up
2015$93.00M 11.9% down
2014$105.60M 40.6% up
2013$75.08M 5.2% up
2012$71.36M 10.2% up
2011$64.78M 16.6% up
2010$55.56M 38.4% up
2009$40.14M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on ANIK

Anika Therapeutics, Inc., figure by figure

Anika Therapeutics, Inc. (ANIK) overview: price, valuation and scorecard

Anika Therapeutics, Inc. revenue: questions and answers

What is Anika Therapeutics, Inc.'s revenue?

Anika Therapeutics, Inc. (ANIK) reported revenue of $112.82M in fiscal 2025 (the year ended December 31, 2025). That is 5.9% lower than the $119.91M of fiscal 2024.

What is the growth rate of Anika Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 2.9% a year; over ten years the rate was 2.0% a year.

What are the highest and lowest revenue figures on record for Anika Therapeutics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $147.79M in fiscal 2021 and the lowest $40.14M in fiscal 2009.

How is Anika Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Anika Therapeutics, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Anika Therapeutics, Inc. (ANIK) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ANIK/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.